Letrozole (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Letrozole drug offered from KAISER FOUNDATION HOSPITALS. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | letrozole |
| SUBSTANCE NAME: | LETROZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-02-05 |
| END MARKETING DATE: | 0000-00-00 |
Letrozole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Letrozole from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2015-02-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0169_3b8c2c45-828b-4ed3-ba08-042665c94f1c |
| PRODUCT NDC: | 0179-0169 |
| APPLICATION NUMBER: | ANDA090934 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers:
